Scientists have found that the amyloid-beta protein, currently the target of Alzheimer’s drug research, is essential for normal information transfer through nerve cell networks in the brain. “If this protein is removed from the brain,” says one of the researchers, “it may cause an impairment of neuronal function, as well as a further and faster accumulation of amyloid-beta in Alzheimer’s.”